Net Cash Provided by (Used in) Financing Activities in USD of Boundless Bio, Inc. from Q1 2023 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Boundless Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q1 2023 to 2024.
  • Boundless Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was -$924K, a 3081% decline year-over-year.
  • Boundless Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $89.8M, a 8.25% decline from 2023.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Boundless Bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$924K -$955K -3081% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q1 2023 $31K 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024

Boundless Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $89.8M -$8.07M -8.25% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 $97.9M 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.